News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
397,026 Results
Type
Article (31956)
Company Profile (58)
Press Release (365012)
Section
Business (112848)
Career Advice (1325)
Deals (24056)
Drug Delivery (93)
Drug Development (59769)
Employer Resources (104)
FDA (9937)
Job Trends (9082)
News (211621)
Policy (25512)
Tag
2024 BioCapital Digital (1)
2024 BioMidwest Digital (1)
2024 Bio NC Digital (1)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (4)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (1)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (1)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (1)
2026 BioCapital Standard (1)
2026 Pharm Country Premier (1)
Academia (1838)
Accelerated approval (1)
Adcomms (20)
Allergies (65)
Alliances (42253)
ALS (58)
Alzheimer's disease (1089)
Antibody-drug conjugate (ADC) (88)
Approvals (9942)
Artificial intelligence (147)
Autoimmune disease (14)
Automation (6)
Bankruptcy (236)
Best Places to Work (7694)
BIOSECURE Act (15)
Biosimilars (79)
Biotechnology (42)
Bladder cancer (45)
Brain cancer (25)
Breast cancer (173)
Cancer (1488)
Cardiovascular disease (120)
Career advice (1112)
Career pathing (19)
CAR-T (101)
Cell therapy (284)
Cervical cancer (15)
Clinical research (48154)
Collaboration (643)
Compensation (371)
Complete response letters (19)
COVID-19 (2471)
CRISPR (29)
C-suite (105)
Cystic fibrosis (56)
Data (1419)
Decentralized trials (1)
Denatured (9)
Depression (35)
Diabetes (203)
Diagnostics (3552)
Digital health (10)
Diversity (4)
Diversity, equity & inclusion (33)
Drug discovery (82)
Drug pricing (95)
Drug shortages (28)
Duchenne muscular dystrophy (76)
Earnings (40311)
Editorial (32)
Employer branding (13)
Employer resources (94)
Events (45665)
Executive appointments (291)
FDA (10721)
Featured Employer (18)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (5)
Funding (442)
Gene editing (71)
Generative AI (12)
Gene therapy (219)
GLP-1 (671)
Government (4068)
Grass and pollen (4)
Guidances (34)
Healthcare (11414)
Huntington's disease (18)
IgA nephropathy (19)
Immunology and inflammation (78)
Indications (21)
Infectious disease (2600)
Inflammatory bowel disease (75)
Inflation Reduction Act (7)
Influenza (47)
Intellectual property (67)
Interviews (231)
IPO (10442)
IRA (40)
Job creations (1748)
Job search strategy (958)
Kidney cancer (7)
Labor market (15)
Layoffs (270)
Leadership (7)
Legal (7048)
Liver cancer (49)
Lung cancer (216)
Lymphoma (101)
Machine learning (4)
Management (32)
Manufacturing (203)
MASH (51)
Medical device (5942)
Medtech (5943)
Mergers & acquisitions (13978)
Metabolic disorders (558)
Multiple sclerosis (49)
NASH (20)
Neurodegenerative disease (64)
Neuropsychiatric disorders (22)
Neuroscience (1449)
NextGen: Class of 2025 (3659)
Non-profit (2769)
Northern California (1529)
Now hiring (4)
Obesity (319)
Opinion (190)
Ovarian cancer (52)
Pain (47)
Pancreatic cancer (63)
Parkinson's disease (103)
Partnered (12)
Patents (145)
Patient recruitment (55)
Peanut (38)
People (24818)
Pharmaceutical (18)
Pharmacy benefit managers (10)
Phase I (14559)
Phase II (20923)
Phase III (16959)
Pipeline (823)
Podcasts (37)
Policy (101)
Postmarket research (1846)
Preclinical (6017)
Press Release (28)
Prostate cancer (73)
Psychedelics (28)
Radiopharmaceuticals (211)
Rare diseases (255)
Real estate (2578)
Recruiting (44)
Regulatory (16078)
Reports (22)
Research institute (1592)
Resumes & cover letters (196)
Rett syndrome (2)
RNA editing (3)
RSV (44)
Schizophrenia (59)
Series A (72)
Series B (38)
Service/supplier (4)
Sickle cell disease (37)
Southern California (1259)
Special edition (5)
Spinal muscular atrophy (137)
Sponsored (18)
Startups (1884)
State (1)
Stomach cancer (11)
Supply chain (47)
The Weekly (26)
United States (12509)
Vaccines (686)
Venture capitalists (24)
Webinars (5)
Weight loss (240)
Women's health (13)
Worklife (9)
Date
Today (145)
Last 7 days (488)
Last 30 days (1859)
Last 365 days (21561)
2025 (5228)
2024 (22364)
2023 (25268)
2022 (33399)
2021 (35905)
2020 (34108)
2019 (27915)
2018 (21235)
2017 (20191)
2016 (18715)
2015 (21499)
2014 (15968)
2013 (12890)
2012 (13639)
2011 (14423)
2010 (13094)
Location
Africa (571)
Alabama (29)
Alaska (3)
Arizona (87)
Arkansas (5)
Asia (25925)
Australia (4668)
California (3336)
Canada (1137)
China (339)
Colorado (144)
Connecticut (150)
Delaware (92)
Europe (62033)
Florida (505)
Georgia (121)
Hawaii (1)
Idaho (28)
Illinois (275)
India (21)
Indiana (181)
Iowa (6)
Japan (110)
Kansas (59)
Kentucky (15)
Louisiana (7)
Maine (27)
Maryland (617)
Massachusetts (2405)
Michigan (99)
Minnesota (131)
Mississippi (1)
Missouri (47)
Montana (20)
Nebraska (10)
Nevada (34)
New Hampshire (20)
New Jersey (1061)
New Mexico (15)
New York (1016)
North Carolina (486)
North Dakota (4)
Northern California (1529)
Ohio (108)
Oklahoma (6)
Oregon (10)
Pennsylvania (741)
Puerto Rico (4)
Rhode Island (12)
South America (796)
South Carolina (10)
South Dakota (1)
Southern California (1259)
Tennessee (52)
Texas (425)
Utah (75)
Virginia (84)
Washington D.C. (35)
Washington State (283)
West Virginia (2)
Wisconsin (27)
397,026 Results for "itm isotopen technologien muenchen ag".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ITM Announces Updates to Commercial Leadership
March 14, 2025
·
4 min read
Press Releases
ITM Appoints Dr. Celine Wilke as Chief Medical Officer
April 1, 2025
·
3 min read
Press Releases
ITM to Present at Raymond James Private Biotech Symposium
February 18, 2025
·
1 min read
Press Releases
ITM and Ariceum Therapeutics Enter Into Supply Agreement for Therapeutic Medical Radioisotope Actinium-225
January 13, 2025
·
5 min read
Press Releases
ITM Presents Positive Topline Phase 3 COMPETE Trial Data with n.c.a. 177Lu-edotreotide (ITM-11), a Targeted Radiopharmaceutical Therapy, in Patients with Grade 1 or 2 Gastroenteropancreatic Neuroendocrine Tumors at the ENETS 2025 Conference
March 6, 2025
·
8 min read
Press Releases
ITM Announces Positive Topline Results of Phase 3 COMPETE Trial with ITM-11, a Targeted Radiopharmaceutical Therapy, in Patients with Grade 1 or Grade 2 Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
January 28, 2025
·
6 min read
Press Releases
ITM to Present at Oppenheimer’s 35th Annual Healthcare Life Sciences Conference
February 7, 2025
·
1 min read
Press Releases
ITM to Participate in Upcoming Investor Conferences
November 11, 2024
·
1 min read
Press Releases
ITM to Present at the 43rd Annual J.P. Morgan Healthcare Conference
December 13, 2024
·
1 min read
Business
ITM Appoints Dr. Danielle Meyrick as Chief Medical Officer
ITM Isotope Technologies Munich SE, a leading radiopharmaceutical biotech company, announced the appointment of Danielle Meyrick, PhD, MD, as Chief Medical Officer.
May 7, 2024
·
4 min read
1 of 39,703
Next
